Correlation Between Gracell Biotechnologies and Kalvista Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Gracell Biotechnologies and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gracell Biotechnologies and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gracell Biotechnologies and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Gracell Biotechnologies and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gracell Biotechnologies with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gracell Biotechnologies and Kalvista Pharmaceuticals.

Diversification Opportunities for Gracell Biotechnologies and Kalvista Pharmaceuticals

0.0

Correlation Coefficient

Gracell Biotechnologies  Kalvista Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Gracell and Kalvista is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gracell Biotechnologies and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Gracell Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gracell Biotechnologies are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Gracell Biotechnologies i.e., Gracell Biotechnologies and Kalvista Pharmaceuticals go up and down completely randomly.

Pair Corralation between Gracell Biotechnologies and Kalvista Pharmaceuticals

If you would invest  839.00  in Kalvista Pharmaceuticals on December 30, 2024 and sell it today you would earn a total of  354.00  from holding Kalvista Pharmaceuticals or generate 42.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Gracell Biotechnologies  vs.  Kalvista Pharmaceuticals

Gracell Biotechnologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Gracell Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Gracell Biotechnologies is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Kalvista Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Kalvista Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Kalvista Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Gracell Biotechnologies and Kalvista Pharmaceuticals

The main advantage of trading using opposite Gracell Biotechnologies and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gracell Biotechnologies position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.

The idea behind Gracell Biotechnologies and Kalvista Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.